Imipenem resistance in Pseudomonas aeruginosa of animal origin

Journal of Chemotherapy

Volumn 24, Issue 1, 2012, Pages 59-60

  Hamouda, Ahmed ^a   Findlay, Jacqueline ^a   Amyes, Sebastian G B ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CARBAPENEM; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; HOSPITAL INFECTION; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; FECES; IMIPENEM; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, BACTERIAL; RNA, MESSENGER; SWINE;

EID: 84866251999     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/1120009X12Z.00000000012     Document Type: Article

References (9)

1. Gales AC, Jones RN, Turnidge J, Rennie R, Ramphal R. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY antimicrobial surveillance program, 1997-1999. Clin Infect Dis. 2001;32(S2):146-155.
2. Jones ME, Draghi DC, Thornsberry C, Karlowsky JA, Sahm DF, Wenzel RP. Emerging resistance among bacterial pathogens in the intensive care unit - a European and North American surveillance study (2000-2002). Ann Clin Microbiol Antimicrob. 2004;3:14.
3. Yoneyama H, Nakae T. Mechanism of efficient elimination of protein D2 in outer membrane of imipenem-resistant Pseudomonas aeruginosa. Antimicrob Agent Chemother.1993;37:2385-2390.
4. Bonomo RA, Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis. 2006;43:S49-S56.
5. Hamouda A, V ali L, Amyes SGB. Gram-negative non-fermenting bacteria from food-producing animals are low risk for hospital-acquired infections. J Chemother. 2008;20:36-42.
6. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother. 2001;48 (S1):5-16.
7. Miranda G, Kelly C, Soloranzano F, Leanos B, Coria R, Patterson JE. Use of pulsed-field gel electrophoresis typing to study an outbreak of infection due to Serratia marcescens in a neonata l intensive care unit. J Clin Microbiol. 1996;34:3138-3141.
8. Wu T, Siu LK, Su L, Lauderale TL, Lin FM, Leu H. Outer membrane protein change combined with co-existing TEM-1 and SHV-1 beta-lactamases lead to false identification of ESBL-producing Klebsiella pneumoniae. J Antimicrob Chemother. 2001;47:755-761.
9. Wolter DJ, Hanson ND, Lister PD. Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance. FEMS Microbiol Lett. 2004;236:137-143.